Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.70 |
| ▸ | HPGD | P15428 | 3/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | HTR1B | P28222 | 6/20 | 0.59 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.59 |
| ▸ | CNR2 | P34972 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | HTR1D | P28221 | 2/20 | 0.54 |
| ▸ | OGG1 | O15527 | 1/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | HRH1 | P35367 | 1/20 | 0.53 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29865765 | 1.00 | KDM4E (0.70) | KDM4EALDH1A1HPGDTDP1KCNA3 | |
| SCHEMBL29865493 | 0.92 | KDM4E (0.68) | KDM4EALDH1A1HPGDTDP1KCNA3 | |
| SCHEMBL5488944 | 0.92 | KDM4E (0.68) | KDM4EALDH1A1HPGDTDP1KCNA3 | |
| SCHEMBL20911356 | 0.90 | CNR2 (0.71) | KDM4EALDH1A1HPGDTDP1KCNA3 | |
| SCHEMBL29865967 | 0.90 | CNR2 (0.71) | KDM4EALDH1A1HPGDTDP1KCNA3 | |
| SCHEMBL8357769 | 0.89 | CNR2 (0.69) | KDM4EALDH1A1HPGDTDP1KCNA3 | |
| SCHEMBL20886144 | 0.89 | CNR2 (0.69) | KDM4EALDH1A1HPGDTDP1KCNA3 | |
| SCHEMBL4294120 | 0.89 | CNR2 (0.69) | KDM4EALDH1A1HPGDTDP1KCNA3 | |
| SCHEMBL29865585 | 0.89 | CNR2 (0.69) | KDM4EALDH1A1HPGDTDP1KCNA3 | |
| SCHEMBL29865545 | 0.89 | CNR2 (0.69) | KDM4EALDH1A1HPGDTDP1KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4766220-A | REACTING OPTICALLY ACTIVE ALKALI METAL SALTS OF 2-HALOGENOALKANOIC ACIDS AND PHENOLS IN WATER WITH HEATING AT REDUCED PRESSURE | RHONE-POULENC AGROCHIMIE (FR) | 1988-08-23 | — | — | US | claimed |
| JP-62201572-A | — | — | None | — | — | JP | disclosed |
| JP-54076823-A | — | — | None | — | — | JP | disclosed |
| JP-62010041-A | — | — | None | — | — | JP | disclosed |
| US-20190106592-A1 | HYPERBRANCHED POLYMERS FOR ORGANIC PIGMENT DISPERSIONS AND WATER-SENSITIVE PIGMENTS | BASF COATINGS GMBH (DE) | 2019-04-11 | — | — | US | disclosed |
| EP-2146574-B1 | PROCESS FOR MANUFACTURE OF HIGH PURITY D-(-)-N, N-DIETHYL-2-( - NAPHTHOXY) PROPIONAMIDE | UPL LTD (IN) | 2015-11-04 | — | — | EP | disclosed |
| EP-2146574-A2 | PROCESS FOR MANUFACTURE OF HIGH PURITY D-(-)-N, N-DIETHYL-2-( - NAPHTHOXY) PROPIONAMIDE | United Phosphorus Limited (IN) | 2010-01-27 | — | — | EP | disclosed |
| WO-2009004642-A2 | PROCESS FOR MANUFACTURE OF HIGH PURITY D-(-)-N, N-DIETHYL-2-(α- NAPHTHOXY) PROPIONAMIDE | UNITED PHOSPHORUS LIMITED (IN) | 2009-01-08 | — | — | WO | disclosed |
| US-20080107829-A1 | Cellulose compound, cellulose film, optical compensation sheet, polarizing plate, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2008-05-08 | — | — | US | disclosed |
| US-7157430-B2 | (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases | IDUN PHARMACEUTICALS, INC. (US) | 2007-01-02 | — | — | US | disclosed |
| US-6242422-B1 | (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases | IDUN PHARMACUETICALS, INC. | 2001-06-05 | — | — | US | disclosed |
| WO-2000023421-A1 | (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES | IDUN PHARMACEUTICALS, INC. (US) | 2000-04-27 | — | — | WO | disclosed |
| US-4766220-A | REACTING OPTICALLY ACTIVE ALKALI METAL SALTS OF 2-HALOGENOALKANOIC ACIDS AND PHENOLS IN WATER WITH HEATING AT REDUCED PRESSURE | RHONE-POULENC AGROCHIMIE (FR) | 1988-08-23 | — | — | US | disclosed |
| EP-0122426-B1 | OPTICALLY ACTIVE CHROMAN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES | BASF Aktiengesellschaft (DE) | 1988-01-27 | — | — | EP | disclosed |
| JP-S62201572-A | INDUCING MEDIUM FOR CALLUS | MITSUI TOATSU CHEM INC | 1987-09-05 | — | — | JP | disclosed |
| US-4645845-A | Novel optically active chroman derivatives, their preparation and novel intermediates | BASF AKTIENGESELLSCHAFT (DE) | 1987-02-24 | — | — | US | disclosed |
| JP-S6210041-A | NAPHTHOXYPROPIONIC ACID DERIVATIVE, PRODUCTION THEREOF AND HERBICIDE CONTAINING SAID DERIVATIVE AS ACTIVE COMPONENT | SUMITOMO CHEM CO LTD | 1987-01-19 | — | — | JP | disclosed |
| EP-0122426-A2 | Optically active chroman derivatives, process for their preparation and intermediates | BASF Aktiengesellschaft (DE) | 1984-10-24 | — | — | EP | disclosed |
| JP-S5476823-A | HERBICIDAL COMPOSITION FOR PADDY RICE FIELD. | MITSUI TOATSU CHEM INC | 1979-06-19 | — | — | JP | disclosed |
| JP-S05476823-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190106592-A1 | HYPERBRANCHED POLYMERS FOR ORGANIC PIGMENT DISPERSIONS AND WATER-SENSITIVE PIGMENTS | TYR, PAH, AHR | KDM4E 3003/4885ALDH1A1 224/4885HPGD 346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.